Multiple Myeloma
Multiple Myeloma is a type of cancer that forms in plasma cells, a kind of white blood cell responsible for producing antibodies. It can lead to various health issues, including bone pain and anemia.
Multiple Myeloma: JNJ-79635322 Treatment Study
We are exploring a new drug combined with existing therapies for patients with multiple myeloma. The goal is to see if this combination improves treatment outcomes.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Stichting Amsterdam UMC
Hematology
Amstelveen, Netherlands
Universitair Medisch Centrum Utrecht
Hematology
De Bilt, Netherlands
Universitair Medisch Centrum Groningen
Hematology
Groningen, Netherlands
Sponsor: Janssen Cilag International
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.